Dominant-Negative Smad2 Mutants Inhibit Activin/Vg1 Signaling and Disrupt Axis Formation in Xenopus  by Hoodless, Pamela A. et al.
GS
S
s
i
c
f
o
i
a
T
v
1
t
d
p
B
m
a
a
s
a
K
a
Developmental Biology 207, 364–379 (1999)
Article ID dbio.1998.9168, available online at http://www.idealibrary.com onDominant-Negative Smad2 Mutants Inhibit
Activin/Vg1 Signaling and Disrupt Axis
Formation in Xenopus
Pamela A. Hoodless,* Tomoo Tsukazaki,* Shin-ichiro Nishimatsu,†
Liliana Attisano,‡ Jeffrey L. Wrana,*,§ and Gerald H. Thomsen†,1
*Program in Developmental Biology, The Hospital for Sick Children, Toronto, Ontario M5S
1A8, Canada; †Department of Biochemistry and Cell Biology, Institute of Cell and
Developmental Biology, State University of New York at Stony Brook, Stony Brook, New York
11796-5215; and ‡Department of Anatomy and Cell Biology and §Department of Medical
enetics and Microbiology, University of Toronto, Toronto, Ontario M5S 1X8, Canada
mads are central mediators of signal transduction for the TGFb superfamily. However, the precise functions of
mad-mediated signaling pathways in early development are unclear. Here we demonstrate a requirement for Smad2
ignaling in dorsoanterior axis formation during Xenopus development. Using two point mutations of Smad2 previously
dentified in colorectal carcinomas, we show that Smad2 ushers Smad4 to the nucleus to form a transcriptional activation
omplex with the nuclear DNA-binding protein FAST-1 and that the mutant proteins interact normally with FAST-1 but
ail to recruit Smad4 into the nucleus. This mechanism of inhibition specifically restricts the dominant-negative activity
f these mutants to the activin/Vg1 signaling pathway without inhibiting BMPs. Furthermore, expression of these mutants
n Xenopus animal caps inhibits but does not abolish activin and Vg1 induction of mesoderm and in the embryo results in
truncated dorsoanterior axis. These studies define a mechanism through which mutations in Smad2 may block
GFb-dependent signaling and suggest a critical role for inductive signaling mediated by the Smad2 pathway in Xenopusorganizer function. © 1999 Academic Press
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Growth factors in the TGFb superfamily regulate a wide
ariety of developmental decisions (reviewed in Hogan,
996; Hoodless and Wrana, 1997; Slack, 1994). In particular,
hese factors have emerged as important inductive signals
uring gastrulation and the early establishment of the body
lan. In Xenopus blastula-stage embryos, activins, Vg1,
MPs, and nodal-related factors have been shown to induce
esoderm and affect its patterning along the dorsal–ventral
nd anterior–posterior axes. For example, expression of
ctivin or Vg1 on the ventral side of an embryo induces a
econd dorsal axis, suggesting that these factors can induce
nd pattern dorsal mesoderm and neural tissue (reviewed in
essler and Melton, 1994; Heasman, 1997). In Xenopus
nimal cap explants, activin and Vg1 induce dorsal meso-b
v
1 To whom correspondence should be addressed. E-mail:
gthomsen@notes.cc.sunysb.edu.
364erm differentiation, consistent with this role. In contrast,
MPs can induce ventral mesoderm in animal caps and are
apable of inhibiting neural differentiation in the animal
ap ectoderm. Furthermore, it has been demonstrated that
ifferent types of mesoderm and endoderm can be induced
epending on the concentration of activin. This has led to
he model that activin can act as a morphogen such that a
oncentration gradient of the ligand will dictate the cell fate
roducing the diversity of patterning required in the em-
ryo (reviewed in Smith, 1995; Neumann and Cohen, 1997).
In recent years, an understanding of the mechanisms of
GFb signal transduction has provided insights into the
function of TGFb signals in developing embryos (reviewed
n Whitman, 1998). TGFb family members interact with
ransmembrane receptor complexes which are composed of
wo distinct serine/threonine kinases, the type I and type II
eceptors (reviewed in Heldin et al., 1997). Upon ligand
inding, the type II receptor transphosphorylates and acti-
ates the type I receptor, which then transmits the signal
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365Inhibition of Smad2 Signaling in Xenopusinto the cell by directly phosphorylating members of a
family of intracellular proteins known as Smads (reviewed
in Attisano and Wrana, 1998; Kretzschmar and Massague´,
998; Heldin et al., 1997; Whitman, 1998). Within the cell,
ignaling by TGFb family members separates into two
istinct pathways, the BMP-induced pathway mediated by
he receptor-regulated Smads 1, 5, and 8 and the TGFb/
ctivin-induced pathway acting through Smads 2 and 3.
mad4, originally identified as a tumor suppressor in pan-
reatic cancers (Hahn et al., 1996), can form heteromers
ith receptor-regulated Smads and acts as a common factor
n signaling by both TGFb/activins and BMPs (reviewed in
Attisano and Wrana, 1998; Kretzschmar and Massague´,
1998; Heldin et al., 1997). Thus, activation of signaling
pathways by BMP or TGFb/activin induces phosphoryla-
tion of receptor-regulated Smads, which permits associa-
tion with Smad4 and translocation into the nucleus to
regulate transcriptional responses. While Smad proteins are
capable of interacting directly with DNA (Kim et al., 1997;
awel et al., 1998; Yingling et al., 1997; Dennler et al.,
998; Labbe´ et al., 1998), additional nuclear protein targets
ave been shown to be involved in formation of transcrip-
ional activation complexes (Chen et al., 1996, 1997; Labbe´
t al., 1998; Zhou et al., 1998). Little is known about the
uclear targets of BMP signaling. In response to activin/
GFb signaling, however, Smad2 and Smad4 have been
shown to interact with FAST proteins, members of the
winged-helix family of transcription factors, that bind TGF-
b/activin-responsive DNA elements in the Mix.2 and
oosecoid promoters (Chen et al., 1996, 1997; Labbe´ et al.,
998; Zhou et al., 1998). Three related FAST proteins have
een identified, the Xenopus and human factors, FAST-1,
nd the mouse factor, FAST2. Interestingly, although com-
lexes containing FAST2, Smad2, and Smad4 can activate
ranscription, Smad3 can also form DNA-binding com-
lexes with FAST-2 and Smad4 but these complexes inhibit
ranscriptional activation by the goosecoid element (Labbe´
t al., 1998). Other promoters can be transcriptionally
ctivated by Smad3 (Dennler et al., 1998; Yingling et al.,
997), and this indicates that Smad2 and Smad3 can play
istinct roles in response to TGFb/activin signals. The
pathways used by the TGFb family members, Vg1, and the
odals is not known since the receptors for these ligands
emain to be identified. However, examination of biological
esponses to Vg1 and nodal expression in Xenopus suggests
hat these ligands stimulate an intracellular pathway re-
ated to activin.
The developmental effects of TGFb factors can be mim-
cked by components of their receptor and signal transduc-
ion pathways. Thus ectopic expression of wild-type or
onstitutively activated activin type I receptor can induce
esoderm in Xenopus animal caps (Chang et al., 1997).
imilarly, overexpression of Smad1 and 5 induces ventral
esoderm in animal caps and can ventralize embryos,
hile Smad2 induces dorsal mesoderm in animal caps andctopic axial structures in the ventral portion of the Xeno-
us embryo (Graff et al., 1996; Baker and Harland, 1996;
Copyright © 1999 by Academic Press. All righthomsen, 1996; Suzuki et al., 1997). These observations are
onsistent with a role of Smad1 and 5 in the BMP pathway
nd Smad2 in activin/Vg1 signaling. However, unraveling
he function of TGFb signals in early patterning has been
ampered in part by a lack of reagents that specifically
lock signaling pathways at the ligand, receptor, or intra-
ellular levels. Expression of dominant-negative type I or II
ctivin receptors, for example, interferes with overall em-
ryonic patterning in Xenopus, providing evidence that
signals from activin receptors function in establishing the
mesodermal germ layer (Hemmati-Brivanlou and Melton,
1992; Chang et al., 1997; Dyson and Gurdon, 1997; Schulte-
Merker et al., 1994). However, the specificity of interfer-
ence by these receptors is debatable since these receptors
often disrupt BMP in addition to activin and Vg1 signaling
(Hemmati-Brivanlou and Thomsen, 1995; Chang et al.,
1997; Schulte-Merker et al., 1994). The most specific dis-
ruption of signaling in Xenopus was provided by expression
of the extracellular domain of the type II activin receptor
(ActRIIBexd), which is able to block activin signaling while
only marginally interfering with BMP signaling. This recep-
tor inhibits initial mesoderm formation, indicating that
activin does have an essential role in early Xenopus devel-
opment (Dyson and Gurdon, 1997). Downstream of TGFb
receptors, a mutated version of Smad4 (DPC4) interferes
with early mesodermal gene expression in Xenopus (Lagna
et al., 1996), but since this factor is the common signal
transduction partner for Smad1 and Smad2, it is likely that
its effects are on signaling by BMP or activin-related path-
ways. Interestingly, despite evidence indicating that activin
plays a role in mesoderm induction in Xenopus, mice
deficient in activin A and B are normal during comparable
early stages of development, suggesting that activin may
not regulate gastrulation and mesoderm formation in mam-
mals (Matzuk et al., 1995). However, mice deficient in the
type I activin receptor, ActRIB (ALK4), or Smad2 do exhibit
gastrulation defects, suggesting that an activin-like mole-
cule acting through these components is required for gas-
trulation (Gu et al., 1998; Waldrip et al., 1998; Nomura and
Li, 1998; Weinstein et al., 1998).
We have utilized two Smad2 mutants, P445H and D450E
(Eppert et al., 1996), to investigate the function of the
Smad2 signaling pathway in early Xenopus development.
These mutants, identified in colorectal carcinomas, are
defective in their ability to be phosphorylated (Eppert et al.,
1996) and exhibit dominant-negative effects when ex-
pressed in Xenopus. In order to assess the specificity of the
interference, we determined the mechanism of the
dominant-negative activity. At the molecular level the
mutants interact normally with the nuclear target FAST-1
but are unable to associate with and recruit Smad4 to the
nucleus to form a transcriptional activation complex. Thus
transcriptional complexes responding to activin/Vg1-like
ligands are disrupted while other signaling pathways requir-
ing Smad4 are not disturbed. In embryos expressing Smad2
P445H and D450E, mesoderm induction still occurs but
complete axis formation is inhibited. This dominant-
s of reproduction in any form reserved.
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366 Hoodless et al.negative effect is specific to pathways which require Smad2
since the phenotypic effects of the mutants can be rescued
by wild-type Smad2. These results suggest a mechanism
through which mutations in Smad2 may block signaling
during the development of cancer and show that inhibition
of the Smad2 signaling pathway interferes with dorsal axis
formation.
MATERIALS AND METHODS
Construction of Vectors
Expression constructs for Smad4, Smad2, and the mutants
(P445H and D450E) ActRIIB and ALK4 (ActRIB) were previously
described (Eppert et al., 1996; Macı´as-Silva et al., 1996; Attisano et
l., 1996). For expression of FAST-1 in mammalian cells, myc-
agged FAST-1 (Chen et al., 1996) was subcloned into pCMV5. For
east two-hybrid assays, wild-type and mutant versions of Smad2
nd Smad4 were subcloned into pGBT9 (Clontech) to generate
AL4 DNA-binding domain fusion proteins. For GAL4 activation
omain fusions, full-length FAST-1 and Smad 4 were subcloned
nto pGAD424 (Clontech).
Affinity-Labeling and Phosphate Labeling
For receptor interaction and phosphorylation studies, COS-1
cells were transiently transfected using diethylaminoethyl (DEAE)
dextran. For phosphate labeling, cells were incubated with 32PO4 as
previously described (Hoodless et al., 1996). Affinity-labeled cells
were incubated with 100 pM [125I]activin in medium containing
.2% fetal calf serum at 37°C for 30 min and the receptors were
ross-linked to the ligand as previously described (Macı´as-Silva et
l., 1996). Cells were lysed in lysis buffer containing 10% glycerol
Wrana et al., 1994) and subjected to immunoprecipitation with
nti-Flag M2 monoclonal antibody (IBI, Eastman Kodak) followed
bsorption to protein G–Sepharose (Pharmacia). Immunoprecipi-
ates or aliquots of total lysates were separated by SDS–PAGE and
isualized by autoradiography.
Electrophoretic Mobility Shift Assays (EMSA)
Transiently transfected COS-1 cells were homogenized in buffer
containing 25% glycerol, 50 mM Tris–HCl, pH 8.0, 100 mM KCl,
2 mM DTT, 2 mM sodium vanadate, 10 mM sodium pyrophos-
phate, and 50 mM sodium fluoride. The homogenate was centri-
fuged twice (13,000g) for 10 min at 4°C and stored at 280°C. For the
EMSA, extracts (5 mg of protein) were incubated in a 20-ml reaction
volume on ice for 10 min in 20 mM Hepes, pH 7.9, 20% glycerol,
0.2 mM EDTA, 2 mM DTT, 7.2 mM MgCl2, and 2 mg poly(dI–dC).
A radiolabeled ARE oligonucleotide probe (Huang et al., 1995) was
added (approximately 40,000 cpm or 20 fmol) and incubation
continued for 30 min. For supershift assays, antibodies were added
with the ARE oligonucleotide. The protein–DNA complexes were
separated on a 5% acrylamide gel and visualized as previously
described (Huang et al., 1995).
ImmunofluorescenceCOS-1 cells were transiently transfected with various combina-
tions of untagged Smad4, Flag-tagged Smad2, and myc-tagged
Copyright © 1999 by Academic Press. All rightFAST-1 (full-length) using calcium phosphate–DNA precipitate-
mediated transfection. Cells were fixed in 4% paraformaldehyde
and permeabilized as described previously (Hoodless et al., 1996).
Cells were blocked in 10% goat serum and incubated overnight at
4°C with anti-myc polyclonal antibody, A-14 (1 mg/ml; Santa Cruz
Biotechnology), anti-myc monoclonal antibody, 9E10 (ATCC),
anti-Flag monoclonal antibody, M2 (10 mg/ml), or a Smad4 poly-
clonal antibody generated to a glutathione S-transferase (GST)
fusion protein containing the nonconserved region of Smad4. Cells
were washed in phosphate-buffered saline and incubated with
Texas red (TR)-conjugated goat anti-rabbit IgG and fluorescein
isothiocynate (FITC)-conjugated goat anti-mouse IgG (1:200 dilu-
tion; Jackson Immunologicals) as secondary antibodies. Images
were obtained using a Leica confocal microscope.
Embryological Methods
Mesoderm induction assays in animal caps and RT-PCR were
previously described (Horb and Thomsen, 1997). For activin treat-
ment, caps were cultured with conditioned medium containing
mouse activin A (PIF) (Sokol and Melton, 1991). Lineage tracing
with b-galactosidase was performed by fixing embryos in MEMFA
0.1 M Mops, pH 7.4, 2 mM EGTA, 1 mM MgSO4, 3.7% formalde-
hyde) for 30 min at room temperature, followed by three washes in
13 PBS and then incubation at 37°C in 5 mM K3Fe(CN)6, 5 mM
K4Fe(CN)6, 2 mM MgCl2, and 1 mg/ml X-gal. In situ hybridization
was performed as described (Harland, 1991). For histology, embryos
were fixed in MEMFA followed by 1 h in Bouin’s fixative, dehy-
drated, mounted in paraplast, and sectioned at 8 mm (Thomsen and
elton, 1993).
RESULTS
Expression of Smad2 Mutants Perturbs Early
Patterning in Xenopus Embryos
Smad2 transduces signals from type I TGFb and activin
receptors and our previous work has shown that several
Smad2 mutants isolated from colorectal tumors do not
respond to signals from type I TGFb receptors, nor do they
induce mesoderm in Xenopus animal caps (Eppert et al.,
1996). To gain insights into the function of Smad2 in early
development and to examine the mechanism through
which mutations may result in cancer, we focused on two
Smad2 missense mutants, Smad2 P445H and Smad2
D450E, which harbor mutations in the MH2 domain and
change proline 445 to histidine and aspartic acid 450 to
glutamic acid, respectively. To test whether the mutants
might display dominant-interfering properties, we exam-
ined the ability of these mutants to interfere with activin
signaling in the well-characterized system, Xenopus ecto-
dermal (animal cap) explants. In this assay, treatment of the
animal caps with activin resulted in elongation, reflecting
the cellular movements associated with anterior–posterior
extension, while untreated caps remained spherical (Fig.
1A). In contrast, when embryos were injected with mRNA
encoding either of the Smad2 mutants prior to isolation of
the caps, elongation in response to activin was abolished.
We next investigated the inhibitory effects of the Smad2
s of reproduction in any form reserved.
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367Inhibition of Smad2 Signaling in Xenopusmutants on the molecular responses of animal caps to Vg1
and activin by RT-PCR. We analyzed a panel of markers
which are induced in response to Vg1 or activin in animal
caps and which represent the diversity of mesodermal cell
types which can occur. Cerberus and chordin, which mark
nterior endoderm and head mesoderm (Sasai et al., 1995;
ouwmeester et al., 1996), were strongly induced by treat-
ent with activin and this induction was potently inhib-
ted by either P445H or D450E (Fig. 1B). Moreover, induc-
ion of cerberus and chordin by processed Vg1 (BVg1;
homsen and Melton, 1993) was also inhibited by the
utants, demonstrating that Smad2 mediates signals by
oth activin and Vg1. Induction of the Spemann organizer
enes, Xlim-1 and goosecoid, were inhibited in the case of
ctivin but this inhibition was not as strong with Vg1. Since
he Vg1 ligand was produced by injection of the mRNA into
he embryos, this may reflect differences in ligand concen-
rations. Induction by activin or Vg1 of the ventrolateral
esoderm markers Xhox3 and Xwnt-8 and the general
esoderm marker brachyury (Xbra) was affected to a lesser
egree although some inhibition was still observed (Fig. 1B).
hese results demonstrate that P445H and D450E have
ominant-negative properties consistent with a role for
mad2 in activin and Vg1 signaling. Furthermore, although
ctivin/Vg1 signaling is disrupted by the mutants, this
FIG. 1. Smad2 mutants function as dominant-negatives to inhib
ctivin are blocked by Smad2 mutants. Animal caps were injected
reated with conditioned medium containing activin. Caps were a
aps, (ii) activin-treated caps, (iii) caps injected with P445H mRN
reated with activin. (B) Induction of mesodermal marker genes by
ertilized eggs was injected with mRNA encoding vector sequence
ubsequently injected into one animal pole blastomere at the 8- to
tage 11 (midgastrula). Expression of mesodermal marker genes, as
recovery. The experiment was repeated at least three times and rep
the embryo were deliberately underloaded to avoid overexposure.nhibition is not complete, suggesting that the mutants do
ot completely block these signaling pathways.
i
a
Copyright © 1999 by Academic Press. All rightThe Mutants P445H and D450E Interact with
ALK4 but Are Not Phosphorylated
Expression of mutant components of TGFb signaling
athways, such as ligands or receptors, often disrupts both
MP and activin signaling pathways. To assess the speci-
city of the Smad2 mutants, we examined the mechanism
hrough which the mutants exert their dominant-negative
ction. Smad2 is regulated by rapid phosphorylation in
esponse to both TGFb and activin signaling, and in the
case of TGFb, this is directly mediated by the TGFb type I
eceptor kinase (Macı´as-Silva et al., 1996). However, TGFb
receptors are absent during early Xenopus development
(Bhushan et al., 1994) and it is more likely that the Smad2
mutants function by disrupting endogenous, activin-like
signals. Thus, we focused our investigations on the role of
wild-type and mutant Smad2 in activin signaling.
Previous studies with the mutants P445H and D450E
showed that they are not phosphorylated in response to
TGFb (Eppert et al., 1996). In order to examine phosphory-
ation of the mutants by activin signaling, COS-1 cells were
ransiently transfected with flag-tagged versions of wild-
ype, P445H, or D450E Smad2, together with either the
ild-type or a constitutively active form of the type I
ctivin receptor, ALK4 (also known as ActRIB). Cells were
ivin/Vg1 signaling. (A) Morphogenetic movements in response to
mRNA encoding the Smad2 mutants P445H or D450E (3 ng) and
ed when control embryos reached neurula stage 18. (i) Untreated
d treated with activin, (iv) caps injected with D450E mRNA and
or activin was inhibited by Smad2 mutants. The animal pole of
, P445H, or D450E. In the BVg1 assays, 10 pg of BVg1 mRNA was
ell stage. Animal caps were excised at stage 8–9 and harvested at
ated, was scored by RT-PCR. Efl-a expression is a control for RNA
tative results are presented. RT1 exposures for organizer genes init act
with
ssess
A an
Vg1
s (2)
16-c
indicncubated with 32PO4 and immunoprecipitated Smad2 was
nalyzed. Similar to the results with TGFb signaling, nei-
s of reproduction in any form reserved.
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368 Hoodless et al.ther the P445H nor the D450E mutants were phosphory-
lated in response to activin signaling (Fig. 2A). Since phos-
phorylation of receptor-regulated Smads by ser/thr kinase
receptors leads to their dissociation from the receptor
(Macı´as-Silva et al., 1996), we investigated whether the
FIG. 2. (A) The Smad2 mutant proteins are not phosphorylated by
flag-tagged wild-type or mutant (P445H and D450E) Smad2 in the
ALK4. Cells were incubated with 32PO4 and Smad2 was immuno
visualized by SDS–PAGE and autoradiography (top). Equal amoun
extracts (bottom). (B) Association of the Smad2 mutants with activ
wild-type or mutant (P445H and D450E) Smad2 together with the
ALK4, as indicated. The receptors were affinity-labeled with 100 p
with anti-flag M2 antibody as previously described (Macı´as-Silva et
DS–PAGE and autoradiography (left). To confirm equivalent level
right).Smad2 mutants might block activin signaling by forming a
stable complex with the receptors. COS-1 cells were tran- a
Copyright © 1999 by Academic Press. All rightiently transfected with flag-tagged wild-type, P445H, or
450E Smad2, together with the activin type II receptor,
ctRIIB, and either the wild-type or kinase-deficient ALK4.
he kinase-deficient version was included since in the case
f TbRI, catalytically inactive receptor is required to trap
ype I activin receptor. Cos-1 cells were transiently transfected with
nce (2) or presence of wild-type (WT) or constitutively active (A)
ipitated with anti-flag M2 antibody. Smad2 phosphorylation was
Smad2 protein were confirmed by Western blotting of total cell
ceptors. COS-1 cells were transiently transfected with flag-tagged
in receptors, ActRIIB and wild-type (WT) or kinase-deficient (KR)
25I]activin and cell lysates were subjected to immunoprecipitation
996; Attisano et al., 1992). Receptor complexes were visualized by
eceptor expression, total cell lysates were analyzed by SDS–PAGEthe t
abse
prec
ts of
in re
activ
M [1
al., 1the transiently associated Smad2 substrate (Macı´as-Silva et
l., 1996). To detect the interaction, the receptors were
s of reproduction in any form reserved.
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369Inhibition of Smad2 Signaling in Xenopusaffinity-labeled with [125I]activin and immunoprecipitates of
mad2 were analyzed. Contrary to our hypothesis, wild-
ype activin receptors did not coprecipitate with either
ild-type Smad2 or the mutants, indicating that the muta-
ions do not stabilize the association with the wild-type
eceptor (Fig. 2B). However, in cells expressing a kinase-
eficient ALK4, comparable levels of receptor complexes
ere detected coprecipitating with Smad2 in all cases,
ndicating that the mutations do not cause major confor-
ational changes that prevent interaction with the type I
inase. These observations are in contrast to our previous
eport that phosphorylation site mutants of Smad2 interact
tably with the TGFb receptor (Macı´as-Silva et al., 1996).
o determine whether this is a feature of the activin
eceptor, we also tested the interaction of Smad2(3SA), a
utant in which the phosphorylation site at the
-terminus is mutated (Macı´as-Silva et al., 1996). Similar
o the P445H and D450E mutants, we observed that
mad2(3SA) stably associated with activin receptor com-
lexes containing kinase-deficient ALK4 but not wild-type
ype I receptors (data not shown). Furthermore, we found
hat the P445H and D450E mutants interacted stably with
ild-type TGFb receptors, providing a potential mecha-
ism for blocking TGFb signaling (S. Abdollah and J.L.W.,
unpublished results). It is currently unclear why phosphor-
ylation mutants of Smad2 do not associate stably with the
activin receptor. Nevertheless, these data suggest that the
mutants may have additional dominant-negative activities
that do not involve preventing access of wild-type Smad2 to
receptors.
Smad2 Mutants Fail to Recruit Cytosolic Smad4
into a Nuclear Complex with FAST-1
Upon activin stimulation, Smad2 associates with Smad4,
accumulates in the nucleus, and interacts with the DNA-
binding protein, FAST-1 or FAST2 (reviewed in Attisano
and Wrana, 1998; Kretzschmar and Massague´, 1998; Heldin
et al., 1997; Whitman, 1998). Smad2, Smad4, and either
FAST-1 or FAST2 are components of a TGFb/activin re-
sponse factor (T/ARF), which binds to the activin response
element (T/ARE) located in the promoter of the Xenopus
Mix.2 or mammalian goosecoid genes, respectively (Huang
et al., 1995; Chen et al., 1997; Labbe´ et al., 1998). To
etermine whether any of these functions of Smad2 are
ffected by the point mutations, we examined the forma-
ion of an ARF in response to activin signaling by EMSA. In
xtracts from Cos cells expressing flag-tagged Smad2,
mad4, and myc-tagged Xenopus FAST-1, a distinct ARF
was observed which was enhanced in the presence of
constitutively active ALK4 (Fig. 3A). This complex was
shifted by preincubation with myc, flag, or Smad4 antibod-
ies, confirming that the ARF contains a complex of all three
components (Chen et al., 1997; Liu et al., 1997). We then
examined whether the Smad2 mutants could support for-
mation of an ARF. In contrast to wild-type Smad2, cells
expressing the mutant P445H formed only a minimal
a
t
Copyright © 1999 by Academic Press. All rightamount of ARF, and this was not enhanced in the presence
of constitutively active receptor (Fig. 3A). Furthermore, we
were unable to detect any ARF formation in cells expressing
Smad2 D450E. Thus, both mutants are defective in their
ability to support formation of a higher order DNA-binding
complex that is required for activin-induced transcriptional
activation of the Mix.2 promoter.
Previous studies have shown that Smad2, but not Smad4,
directly interacts with FAST-1 and that Smad2 functions to
recruit Smad4 into a complex with FAST-1 to form an ARF.
To determine how the mutants disrupt ARF formation we
examined the interactions of the mutant proteins with
Smad4 and FAST-1 using a yeast two-hybrid system. Inter-
estingly, both the wild-type and the mutant forms of Smad2
interacted equally well with FAST-1 (Fig. 3B), while no
interaction between FAST-1 and Smad4 could be detected,
supporting previous observations (Chen et al., 1997; Liu et
al., 1997). However, when we tested the interaction be-
tween the Smad2 mutants and Smad4, wild-type Smad2
interacted strongly with Smad4 (Chen et al., 1997) while
the mutant D450E did not, and the mutant P445H inter-
acted only weakly (Fig. 3C), correlating with our observa-
tion that a small amount of ARF was formed with this
mutant. This suggests that the Smad2 mutants interact
normally with FAST-1 but are unable to recruit Smad4 into
a complex with FAST-1.
To better understand the mechanism by which Smad2
functions in the recruitment of Smad4 to FAST-1 and to
confirm the dominant-negative action of the Smad2 mu-
tants in intact cells, we examined their subcellular local-
ization by immunofluorescence. This also allowed us to
examine whether the nuclear localization of Smad2 is
affected by the mutations in P445H and D450E. To charac-
terize this whole cell system, we first tested the interac-
tions of these proteins using wild-type versions. COS-1
cells were transfected with various combinations of myc-
tagged FAST-1, flag-tagged Smad2, and untagged Smad4 and
the proteins were localized by confocal microscopy. As
previously demonstrated (Chen et al., 1996), FAST-1 is
lmost exclusively nuclear and its localization is unaffected
y expression of constitutively active ALK4 (Fig. 4C and
ata not shown). In cells expressing Smad2 alone, Smad2
an be seen throughout the cell in equilibrium between the
ytoplasm and the nucleus (Fig. 4A) and activation of
ignaling pathways through either the TGFb or the activin
eceptor resulted in accumulation of Smad2 protein in the
ucleus (data not shown; Baker and Harland, 1996; Macı´as-
ilva et al., 1996). Interestingly, coexpression of Smad2 and
AST-1 in the same cell resulted in a dramatic shift of
mad2 into the nucleus that occurred independent of recep-
or signaling (Figs. 4D–4F), suggesting that overexpression
f a nuclear target can shift the equilibrium of the Smad2
rotein in the absence of signaling. Furthermore, the colo-
alization of Smad2 and FAST-1 (indicated by yellow fluo-
escence in Fig. 4F) suggests that phosphorylation is not
bsolutely required for association. This is consistent with
he strong interactions that we observed between these two
s of reproduction in any form reserved.
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370 Hoodless et al.proteins in yeast, which do not possess a TGFb signaling
system. In contrast, in cells expressing Smad4 alone, Smad4
was observed predominantly in the cytoplasm (Figs. 4B and
5A). Furthermore, coexpression of Smad4 with FAST-1 did
not result in any shift in the localization of Smad4 (Figs.
4G–4I), supporting the observation that Smad4 does not
interact with FAST-1. However, in the presence of Smad2
and FAST-1, Smad4 colocalized with Smad2 in the nucleus,
(Figs. 4J and 4K, and yellow staining in L), supporting the
model that Smad2 is required to recruit Smad4 from the
cytoplasm into a nuclear complex with FAST-1 (Liu et al.,
FIG. 3. Activin response factor formation is inhibited with the
myc-tagged FAST-1, Smad4-HA, and flag-tagged wild-type (WT) or
constitutively active (A) ALK4 as indicated. Cell homogenates w
activin response element (ARE) from the Mix.2 promoter and the pr
assay. The position of the ARF is indicated by the arrow. Addition
(B) FAST-1 directly interacts with wild-type and mutant Smad2 bu
driven by the GAL4 promoter was transformed with FAST-1 fused t
(P445H or D450E) Smad2 or Smad4 (S4) fused to the GAL4 DNA
elative activity was plotted. (C) Smad2 mutants do not interact wit
BD) alone or fused to wild-type (Smad2) or mutant (P445H and D4
r fused to Smad4 (S4). b-Galactosidase activity was measured and1997).
We next used this assay to examine the interactions of
Copyright © 1999 by Academic Press. All rightthe Smad2 mutants. Similar to wild-type Smad2, in cells
expressing either of the mutants alone, the protein was
distributed throughout the cell (Figs. 5B and 5C). Further-
more, coexpression of either Smad2 mutant with FAST-1
resulted in nearly exclusive localization of the mutant
protein in the nucleus (Figs. 5D–5I), supporting our obser-
vations that these point mutations do not disrupt interac-
tions with FAST-1. However, expression of Smad4 together
with FAST-1 and either Smad2 mutant did not result in the
nuclear accumulation of Smad4 (Fig. 5J–5O), in contrast to
results obtained with wild-type Smad2 (Figs. 4J–4L). To-
ad2 mutants. (A) COS-1 cells were transiently transfected with
ant (P445H or D450E) Smad2 along with either wild-type (WT) or
cubated with radiolabeled DNA oligonucleotides containing the
–DNA complexes were analyzed by electrophoretic mobility shift
ti-myc, anti-flag, and anti-Smad4 antibodies is indicated (bottom).
t Smad4. A yeast strain containing a b-galactosidase reporter gene
activation domain (AD) of GAL4 and wild-type (Smad2) or mutant
ing domain (BD). b-galactosidase activity was measured and the
ad4. Yeast were transformed with the GAL4 DNA-binding domain
Smad2 together with the GAL4 activation domain (AD) alone (2)
relative activity was plotted.Sm
mut
ere in
otein
of an
t no
o the
-bind
h Smgether our results clearly demonstrate that Smad2 func-
tions to recruit Smad4 into a nuclear transcription complex
s of reproduction in any form reserved.
371Inhibition of Smad2 Signaling in XenopusFIG. 4. Smad4 requires Smad2 for nuclear localization and interaction with FAST-1. COS-1 cells were transiently transfected with
combinations of flag-tagged Smad2, Smad4, and myc-tagged FAST-1. Smad2 protein was detected with a monoclonal anti-flag antibody with
a FITC anti-mouse secondary antibody (green) and Smad4 protein was visualized using a polyclonal anti-Smad4 antibody with a Texas red
anti-rabbit secondary antibody (red). For FAST-1, either an anti-myc monoclonal (green) or an anti-myc polyclonal antibody (red) was used
as required for double labeling. The expressed proteins were visualized by immunofluorescent confocal microscopy. (A–C) COS-1 cells
singly transfected with flag-Smad2 (A), Smad4 (B), or myc-FAST-1 (C) are shown. (D–F) Flag-Smad2 and myc-FAST-1 were coexpressed in
the same cells, and localization of Flag Smad2 (green, D) and myc FAST-1 (red, E) is shown. Double immunofluorescence demonstrates
colocalization of Smad2 and FAST-1 in the nucleus (yellow, F). (G–I) Smad4 and myc-FAST-1 were coexpressed in the same cells and
localization of Smad4 (red, G) and myc-FAST-1 (green, H) is shown. Double immunofluorescence (yellow, I) demonstrates that Smad4
remains predominantly cytosolic in the presence of nuclear FAST-1. (J–L) Smad4, flag-Smad2, and myc-FAST-1 were coexpressed in the
same cells and localization of flag-Smad2 (green, J) and Smad4 (red, K) is shown. Double immunofluorescence (yellow, L) demonstrates that
Smad4 is predominantly nuclear in the presence of Smad2 and FAST-1.
Copyright © 1999 by Academic Press. All rights of reproduction in any form reserved.
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373Inhibition of Smad2 Signaling in Xenopuswith FAST-1 and show that the mutant proteins, while
retaining the capacity to interact with FAST-1, are not
capable of recruiting Smad4 into a nuclear complex. Thus,
we propose that overexpression of these mutant proteins
may function specifically to block nuclear targets of Smad2
which are activated by activin-like signaling during early
development. Importantly, these mutants are unlikely to
interfere with the function of Smad4, which acts in both
activin and BMP signaling pathways.
Expression of the Smad2 Mutants Disrupts Axis
Formation
To examine the phenotypical effects of reducing activin
or activin-like signals during embryonic development, we
expressed these mutants in Xenopus embryos. Targeted
expression of either P445H or D450E within the dorsal
marginal zone resulted in axis truncation including a loss of
obvious head structures (Figs. 6A and 6C). Embryos injected
with D450E displayed a slightly higher frequency (46%, n 5
27) of the truncated phenotype compared to P445H (37%,
5 121), suggesting that D450E may be a stronger
ominant-negative. Since Smad3 can also mediate activin/
GFb signals, we made mutations of Smad3 at positions
corresponding to the P445H and D450E mutations in
Smad2. Expression of these Smad3 mutants also resulted in
truncations when injected dorsally, identical to those ob-
served with Smad2 (data not shown). Interestingly, the
truncations observed with Smad2 mutants were highly
dependent on the precise targeting of expression to the
organizer and were generated only when the mutants were
expressed in tissues at anterior positions in the embryo.
Expression of these dominant negatives in ventral tissues,
trunk, or tail had no effect demonstrating that BMP signal-
ing was not disrupted by the mutant proteins (Figs. 6B and
6D). This supports the biochemical mechanism of action
for these mutants, indicating that BMP signaling is not
affected. These results contrast with previous studies in
which expression of truncated activin receptors resulted in
strong suppression of mesoderm formation (Hemmati-
Brivanlou and Melton, 1992; Chang et al., 1997). However,
these receptors inhibit BMP signaling and in addition may
FIG. 5. Smad4 does not accumulate in the nucleus in the presence
with combinations of flag-tagged Smad2 mutants, P445H, D450E, S
by immunofluorescent confocal microscopy as described in the le
flag-Smad2 P445H (B), or flag-Smad2 D450E (C) are shown. (D–F) F
and localization of flag-Smad2 P445H (green, D) and myc-FAST-1 (r
Smad2 P445H and FAST-1 colocalize in the nucleus. (G–I) Flag-Sm
localization of flag-Smad2 D450E (green, G) and myc-FAST-1 (red
Smad2 D450E and FAST-1 colocalize in the nucleus. (J–L) Flag Sma
and localization of flag-Smad2 P445H (green, J) and Smad4 (red, K
Smad4 is unable to accumulate in the nucleus in the presence of t
were coexpressed in the same cells and localization of flag-Smad2 D45
rescence (yellow, O) demonstrates that Smad4 is unable to accumulate
Copyright © 1999 by Academic Press. All rightmore strongly inhibit activin signaling. In our experiments,
we did not block mesoderm formation; however, when
higher doses of mutant RNA (. 4 ng) were employed, we
observed further dorsal axis truncation (Fig. 6E), indicating
that these mutants can also partially inhibit trunk forma-
tion. Importantly, coinjection of wild-type Smad2 (0.5 ng)
along with the mutant Smad2 (D450E) into the dorsal
region was able to rescue the truncations (Fig. 6F), demon-
strating that the mutants are specific dominant-negative
inhibitors of the Smad2 signaling pathway. Together our
results suggest that the mutants do not completely block all
mesoderm inducing activities. However, complete axis for-
mation is sensitive to inhibition of the Smad2 pathway,
supporting a role for an activin or activin-like signal in the
induction of the entire range of mesodermal cell types
required for normal development.
DISCUSSION
We have utilized two mutations of Smad2, identified in
colorectal carcinomas, to examine requirements for Smad2
signaling during early Xenopus development. We show that
the receptor-regulated Smad, Smad2, directs interactions
with the nuclear factor FAST-1, by recruiting Smad4 into
nuclear transcription complexes. We further demonstrate
that Smad2 point mutants function as dominant-negative
proteins by preventing recruitment of Smad4 from the
cytoplasm into downstream nuclear complexes. Expression
of these specific dominant-negative Smad2 mutants in
embryos at moderate doses inhibits anterior development
but has little or no effect on trunk and tail formation. In
addition, expression of the mutant proteins in Xenopus
animal caps inhibits the induction of many organizer genes
such as cerberus, chordin, and goosecoid in response to
activin and Vg1. This inhibition is limited, indicating that
activin/Vg1 signaling is not completely blocked by the
mutants and suggests that these mutants reduce but do not
abolish signaling. Activin and Vg1 have been extensively
characterized as general mesoderm inducers in Xenopus,
but our results now further demonstrate that high levels of
e Smad2 mutants, P445H and D450E. COS-1 cells were transfected
4, and myc-tagged FAST-1. The expressed proteins were visualized
to Fig. 3. (A–C) COS-1 cells singly transfected with Smad4 (A),
mad2 P445H and myc-FAST-1 were coexpressed in the same cells
) is shown. Double immunofluorescence (yellow, F) indicates that
D450E and myc-FAST-1 were coexpressed in the same cells and
is shown. Double immunofluorescence (yellow, I) indicates that
45H, Smad4, and myc FAST-1 were coexpressed in the same cells
own. Double immunofluorescence (yellow, L) demonstrates that
mad2 mutant. (M–O) Flag Smad2 D450E, Smad4 and myc FAST-1of th
mad
gend
lag-S
ed, E
ad2
, H)
d2 P4
) is sh
he S0E (green, M) and Smad4 (red, N) is shown. Double immunofluo-
in the nucleus in the presence of the Smad2 mutant.
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374 Hoodless et al.an activin/Vg1-like ligand, mediated through Smad2, can
regulate anterior development.
Mechanism of Smad2 Dominant-Negative Activity
Smad2 is distributed throughout the cell but accumulates
in the nucleus in response to ligand signaling (Macı´as-Silva
et al., 1996). In contrast, Smad4 is predominantly localized
in the cytosol (Liu et al., 1997). Phosphorylation of Smad2
y the type I receptor leads to association with Smad4 and
uclear translocation. Once in the nucleus, Smad2 and
mad4 complex with the nuclear factors FAST-1 or FAST2
o form an ARF (Chen et al., 1997; Labbe´ et al., 1998; Zhou
et al., 1998) which acts as a transcriptional activator to
regulate gene expression (Liu et al., 1997; Labbe´ et al., 1998;
reviewed in Attisano and Wrana, 1998; Kretzschmar and
Massague´, 1998; Heldin et al., 1997; Whitman, 1998).
Transcriptional activation may occur through the associa-
FIG. 6. Expression of the Smad2 mutants inhibits dorsoanterior
njected (3 ng) into the subequatorial dorsal marginal zone (DMZ) a
y coinjection of mRNAs for b-galactosidase (b-gal) and the muta
staining for b-gal was noted in the anterior region of all headless e
ventral marginal zone (B and D) shows normal embryonic develop
regions. (E) Expression of D450E at high levels causes partial disrup
targeted to the dorsal marginal zone of four cell embryos (2.25 ng i
(DAI; Kao and Elinson, 1988) these embryos had an average DAI o
artifact of fixation, not incomplete gastrulation. (F) Coexpression
mutant D450E (average DAI 5 3.8, n 5 19). Most had normal hea
D450E acts in a dominant-negative manner at the phenotypic levetion of Smad proteins with coactivators such as CBP/P300
and MSG-1 (Janknecht et al., 1998; Feng et al., 1998; Topper
D
p
Copyright © 1999 by Academic Press. All rightt al., 1998; Shioda et al., 1998). Here, we have demon-
trated, by examining subcellular localization, that FAST-1
xpression promotes nuclear localization of Smad2. In con-
rast, FAST-1 does not interact directly with Smad4 and
uclear accumulation of Smad4 occurs only in the presence
f Smad2. These observations support Liu et al. (1997) and
ndicate that Smad2 is required to usher Smad4 into the
ucleus and that Smad2 mediates the interaction of Smad4
ith its downstream targets. Since activation of Smad1 by
MPs also leads to interaction with Smad4 (Lagna et al.,
996), BMP-regulated Smads may function in a similar
anner to recruit Smad4, a general partner of receptor-
egulated Smads, into BMP-specific nuclear complexes.
herefore, by controlling the interaction of Smad4 with
ownstream targets, the receptor-regulated Smads play a
ritical role in maintaining the specificity of gene responses
o a particular ligand.
At the molecular level, the Smad2 mutants P445H and
formation. Smad2 P445H (A) or Smad2 D450E (C) mRNA was
4- to 8-cell stage. The injected cells of embryos were lineage traced
ad2, followed by staining for b-gal activity (blue cells). Positive
yos. Coinjection of the Smad mutants and b-gal mRNAs into the
t with lineage-labeled cells populating the trunk, ventral, and tail
of trunk development. Mutant Smad2 D450E mRNA (4.5 ng) was
h of two blastomeres). Rated according to the dorsoanterior index
(n 5 19). Note that some embryos are curved laterally due to an
ild-type Smad2 (0.5 ng total) rescued defects caused by 4.5 ng of
d all had a full body axis. These results demonstrate that mutant
ilar results were observed with mutant P445H (data not shown).axis
t the
nt Sm
mbr
men
tion
n eac
f 2.2
of w450E interact with the type I activin receptor, but phos-
horylation is defective and association with Smad4 is
s of reproduction in any form reserved.
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375Inhibition of Smad2 Signaling in Xenopusblocked. Although the mutants are able to interact with
FAST-1, ARF formation is disrupted and Smad4 is not
recruited into a nuclear complex. This further demonstrates
that nuclear localization of Smad4 requires physical asso-
ciation with Smad2 and that Smad4 is required for efficient
formation of an activin-induced transcriptional activation
complex (Liu et al., 1997; Chen et al., 1997; Labbe´ et al.,
1998). Based on these features we propose that ectopic
expression of Smad2 mutants in Xenopus embryos causes
dominant-negative inhibition by titrating DNA-binding
proteins into transcriptionally nonfunctional nuclear com-
plexes which lack Smad4 (Fig. 7). Since Smad4 is a common
component of TGFb and BMP signaling pathways, this
uggests that the Smad2 mutants do not interfere with BMP
ignaling, consistent with our observation that expression
f the Smad2 mutants in the ventral marginal zone did not
erturb ventral patterning by endogenous BMP signals.
urthermore, since receptor-regulated Smads interact with
pecific nuclear targets to elicit distinct, biological re-
ponses, these mutations provide specific dominant-
egative activity for activin-like receptor pathways.
The Smad2 Mutants Reduce but Do Not Block
Activin Signaling
The mutants P445H and D450E were originally identified
in sporadic colorectal tumors, indicating that disruption of
TGFb signaling can result in loss of sensitivity to negative
rowth regulation. The dominant-negative effects of the
utants may provide a mechanism through which inhibi-
ion of TGFb signaling could result in loss of growth
nhibition. However, this is uncertain since, in the case of
450E, the mutation was accompanied by a loss of het-
rozygosity implied by the absence of wild-type message.
hus, this mechanism of dominant-negative activity may
unction only when the mutant is expressed at high levels
elative to the wild-type protein.
The extent to which these dominant-negative mutants
an inhibit Smad2 functions is unclear. Mesoderm induc-
ion by activin or Vg1 in animal caps was inhibited but not
bolished in the presence of the Smad2 mutant proteins.
he possibility exists that other pathways can overcome
ominant-negative inhibition by the Smad2 mutants in
ome circumstances and thereby reveal inductive events
hich absolutely require functional Smad2. However, it is
ore likely that the Smad2 mutants act as weak dominant-
egatives that reduce the level of Vg1 or activin-like signal-
ng. It is well established that activin and BMPs can
unction in a concentration-dependent manner to effect cell
ate decisions (Smith, 1996; Wilson et al., 1997). High levels
f activin signaling are able to induce dorsoanterior markers
uch as Goosecoid in animal explant cultures while lower
evels can induce mesoderm with a more ventral character,
eflected by expression of Xlhbox6 and Xbra (Green et al.,
992). Furthermore, it is thought that in the embryo,
ctivin or an activin-like factor functions as a morphogen to
orm a concentration gradient (reviewed in Neumann and
Copyright © 1999 by Academic Press. All rightohen, 1997). In animal cap explants treated with activin or
Vg1, we observed that the Smad2 mutant proteins inhib-
ted induction of dorsoanterior markers, such as chordin
nd cerberus, more consistently and more severely than
entral markers such as Xwnt-8. This observation suggests
hat dorsoanterior markers are more sensitive to inhibition
nd may reflect a lower level of ligand signaling in animal
aps expressing the mutant proteins. Thus, these mutants
llow us to examine during development the functions of a
pecific subset of Vg1/activin-like responses that require
igh levels of ligand signaling.
Smad2 Signaling Is Required for Axis Formation
Due to the incomplete but specific nature of the inhibi-
tion, these mutants provide a unique opportunity to exam-
ine the effects of reducing activin-like signals in the embryo
without completely disrupting mesoderm formation. Inter-
estingly, we observed that expression of Smad2 mutants in
the dorsal marginal zone of Xenopus embryos blocked
complete axis formation. This phenotype was highly depen-
dent on the precise targeting of mutant Smad2 expression to
the organizer. If the organizer was not targeted, the tadpoles
routinely developed normally. This points to a crucial role
of a Smad2 signaling pathway for the induction of anterior
axial structures while inhibition of activin/Vg1 activity in
other regions is less critical. Thus, expression of the Smad2
mutants in the embryo may function to reduce signaling in
all cells, resulting in a shift in the signal gradient such that
the highest concentrations are never achieved. This is
supported by expression of extremely large amounts of the
mutant proteins in embryos which resulted in further axial
truncations (see Fig. 6).
It is also interesting to note that expression of the
mutants in the marginal zone of Xenopus sometimes re-
duced but did not abolish Xbra expression and delayed
gastrulation movements (data not shown). However, if
expression was not targeted to the organizer, embryos with
slowed rates of gastrulation eventually finished blastopore
closure, finished axial elongation, and recovered. This pos-
sibly reflects the presence of additional signals in the
ventral marginal zone, such as BMPs, which can compen-
sate for reduced activin signaling. Embryos expressing a
secreted form of the activin type II receptor, ActRIIBexd,
which inhibits activin but only minimally affects BMP
signaling, also experience a delay in Xbra induction and
yield anterior truncations and perturbations in trunk devel-
opment (Dyson and Gurdon, 1997). In addition, delays in
gastrulation similar to the Smad2 effect have been noted for
Smad4 dominant-negative mutants (Lagna et al., 1996).
However, in this case axial truncations were never observed
(G. Lagna and A. Hemmati-Brivanlou, personal communi-
cation), suggesting that disruptions induced by Smad2 mu-
tants are not secondary to delays in gastrulation.
Similar mutations in Smad3 also inhibit axial develop-
ment, indicating that the mutations identified in Smad2
may also affect Smad3 functions. Interestingly, mice lack-
s of reproduction in any form reserved.
376 Hoodless et al.FIG. 7. Mechanism of inhibition by the Smad2 mutant proteins. The mutant proteins (Smad2m) fail to be phosphorylated in response to
ligand. Expressed mutant proteins can interact with FAST-1, blocking recruitment of Smad4 into active transcription complexes.
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377Inhibition of Smad2 Signaling in Xenopusing Smad3 are normal at birth, indicating that Smad3 is not
required for embryonic development in mammals (Zhu et
l., 1998). However, expression of the Smad3 mutant pro-
eins may be able to inhibit Smad2 functions since Smad3
an form complexes with Smad4 and nuclear DNA-binding
roteins, such as FAST-1 and FAST2 (Labbe´ et al., 1998).
hus while the role of Smad3 in Xenopus development
emains to be established, the mutations in Smad3 are
ikely to function identically to the Smad2 mutants to elicit
he same phenotype by inhibiting signaling through activin
eceptors without disrupting BMP pathways.
Our experiments demonstrate that anterior development
n Xenopus is very sensitive to inhibition of Smad2 signal-
ng, suggesting that high levels of an activin/Vg1-like signal
s required in anterior regions of the embryo to permit
omplete axis formation. These observations agree with
ecent experiments in the mouse in which disruption of
mad2 or ActRIB (ALK4) produces defects in proximal–
istal patterning which precedes and is thought to dictate
he anterior–posterior axis (Waldrip et al., 1998; Nomura
and Li, 1998; Gu et al., 1998). Furthermore, mice homozy-
ous for the Smad2 allele Smad2Robm1 show a complete loss
of anterior–posterior patterning and chimeric experiments
indicate that the absence of Smad2 in the extraembryonic
tissues can account for this patterning defect. Although
mesoderm induction still occurs, this mesoderm is entirely
posterior in nature, forming only extraembryonic structures
(Waldrip et al., 1998). The role of Smad2 in mesoderm
induction remains unclear since mice homozygous for
other Smad2 alleles fail to form mesoderm (Nomura and Li,
1998; Weinstein et al., 1998). Mice deficient in Smad4 also
ail to form mesoderm; however, this failure could be due to
isruption of BMP signaling (Sirard et al., 1997; Yang et al.,
998). Interestingly, chimeric embryos with wild-type ex-
raembryonic tissues and Smad4-deficient embryonic tis-
ues exhibit anterior truncations (Sirard et al., 1997).
The precise identity of the TGFb factors involved in axial
formation remains to be identified, although several candi-
dates for this inductive activity include activin-like factors,
Vg1, and nodals (Xnr). Specific disruption of Vg1 (Joseph and
Melton, 1998) and activin (Dyson and Gurdon, 1997) li-
gands blocks dorsal–anterior development, but not ventral–
posterior tissues. In mice deletions of both Activin A and
Activin B do not disrupt gastrulation (Matzuk et al., 1995);
however, nodal has been shown to function in the primitive
endoderm to regulate anterior development (Varlet et al.,
1997). Also, a genetic interaction between Smad2 and nodal
has been reported in mice, suggesting that Smad2 mediates
nodal signaling (Nomura and Li, 1998). The mammalian
homologue of Vg1 has not been identified. Based on the
similar biological effects of nodal and Vg1 compared to
activins, it is likely that nodal and Vg1 also regulate
Smad2-dependent signaling pathways. Supporting this sug-
gestion we have demonstrated here that the Smad2 mutant
proteins can inhibit Vg1 functions. Thus, regardless of the
identity of the ligand(s) in vivo, our results implicate a
Copyright © 1999 by Academic Press. All rightconserved function for Smad2 signaling in mediating dor-
soanterior axis formation in vertebrates.
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